Delivery Order SPE2DB22D3016-SPE2DB25FBJE8
- Not listed
- The Defense Logistics Agency awarded a $2,172.10 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Provayblue 50 mg/10 ml vials. This firm fixed price contract, with an ultimate completion date of September 4, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award involves no set-aside designation and was...
- The Defense Logistics Agency awarded a delivery order valued at $7,306.09 to AmerisourceBergen Drug Corp for Provayblue 50 mg/10 mL ampules on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, firm fixed-price contract involves the supply of pharmaceutical products to be delivered to the company's headquarters location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,838.40 firm fixed-price delivery order is for the supply of PROVAYBLUE 50 MG/10 ML AMPULE 10ML, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of PROVAYBLUE 50 MG/10 ML AMPULE 10ML pharmaceutical products. The fixed-price delivery order, valued at $5,973.29, has an ultimate completion date of October 10, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
- The Defense Logistics Agency Troop Support Medical awarded a $1,378.51 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561924160 ! PROVAYBLUE 50 MG/10 ML VIAL 10ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from August 24, 2023 through August 25, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support in procurement and supply chain...
- This federal contract award is for the delivery of Provayblue 50 mg/10 ml ampules to the Defense Logistics Agency (DLA). The contract, valued at $2,747.82, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,525.62 firm fixed-price delivery order contract is for the supply of "PROVAYBLUE 50 MG/10 ML AMPULE 10ML" and has an ultimate completion date of August 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $40,959.52 to AmerisourceBergen Drug Corp on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. AmerisourceBergen Drug...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of PROVAYBLUE 50 MG/10 ML AMPULE 10ML, a pharmaceutical product, with a ceiling value of $2,210.02 and a period of performance through May 23, 2025. The contract is a Firm Fixed Price type and is not set aside for any specific business category. Amerisourcebergen Drug Corp...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp on August 28, 2025, with completion expected by August 29, 2025. This firm fixed-price delivery order represents a non-competitive award under the company's larger indefinite delivery contract (IDC) vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a leading pharmaceutical distributor and healthcare...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBJE8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,023.70 to AmerisourceBergen Drug Corp for the supply of Provayblue 50 mg/10 ml ampules on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The contract supports multiple federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, as part of DLA's strategic approach to pharmaceutical supply chain management.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/12/25 |